Form 8-K - Current report:
SEC Accession No. 0001062993-25-002033
Filing Date
2025-02-11
Accepted
2025-02-11 10:38:13
Documents
18
Period of Report
2025-02-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K form8k.htm   iXBRL 8-K 27170
2 EXHIBIT 1.1 exhibit1-1.htm EX-1.1 174865
3 EXHIBIT 99.1 exhibit99-1.htm EX-99.1 9853
9 GRAPHIC exhibit99-1x001.jpg GRAPHIC 9919
  Complete submission text file 0001062993-25-002033.txt   515684

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mdcx-20250210.xsd EX-101.SCH 5027
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mdcx-20250210_cal.xml EX-101.CAL 702
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mdcx-20250210_def.xml EX-101.DEF 23107
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mdcx-20250210_lab.xml EX-101.LAB 48758
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mdcx-20250210_pre.xml EX-101.PRE 25856
21 EXTRACTED XBRL INSTANCE DOCUMENT form8k_htm.xml XML 6235
Mailing Address 300 CONSHOHOCKEN STATE RD. SUITE 200 W. CONSHOHOCKEN PA 19428
Business Address 300 CONSHOHOCKEN STATE RD. SUITE 200 W. CONSHOHOCKEN PA 19428 610-540-7515
Medicus Pharma Ltd. (Filer) CIK: 0001997296 (see all company filings)

EIN.: 981778211 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42408 | Film No.: 25608125
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)